Litigation

Recent Posts

Avandia Off Market In Europe; FDA To Restrict Its Use, Orders Probe of GSK Study
Posted on 23 Sep 2010 by Tom Moylan

(Mealey's) The European Medicines Agency (EMA) on Sept. 23 recommended that the marketing authorization for GlaxoSmithKline PLC's (GSK) controversial anti-diabetes drug Avandia be suspended, and the Food and Drug Administration simultaneously... Read More

Tags: diabetes drug , EMA , European Medicines Agency , drugs & devices , Food and Drug Administration , Actos , rosiglitazone , TIDE study , Thiazolidinedione Intervention With Vitamin D Evaluation study , FDA , Litigation , Committee for Medicinal Products for Human Use , GSK , GlaxoSmithKline , pioglitazone , RECORD clinical trial , stroke , Avandia , Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia clinical trial , heart attack

2 Attorneys Settle Their Avandia Cases In Federal, State Courts
Posted on 10 May 2010 by Tom Moylan

PHILADELPHIA — (Mealey’s) Two attorneys have settled their Avandia personal injury cases in federal and state courts with defendant GlaxoSmithKline plc, a source told Mealey Publications May 10. According to the source, W. Mark Lanier of... Read More

Tags: Sol Weiss , insulin , Anapol Schwarz , Food and Drug Administration , rosiglitazone , FDA , Lanier Law Firm , diabetes drugs , Litigation , GSK , GlaxoSmithKline , lawsuit , W. Mark Lanier , diabetes , Avandia